Yangtze River Pharmaceutical (Group) Co., Ltd.

About Yangtze River Pharmaceutical (Group) Co., Ltd.

Yangtze River Pharmaceutical Group (hereinafter referred to as YRPG) is a Chinese large-scale cross-region pharmaceutical group founded in 1971. Till July 2019, with a total area of over 3 million square meters, YRPG owns 14 manufacturing subsidiaries located in Beijing, Shanghai, Nanjing, Guangzhou etc. and has established R&D and production bases of innovative chemical medicine, patent traditional Chinese medicine (TCMs) and biological medicines. 
4 workshops, 6 FDFs and 1 NEX had been EU GMP certified (Enalapril Maleate Tablets, Omeprazole Enteric-coated Capsules, Nifedipin...

  • CN
  • 2015
    On CPHI since
Contact info
  • No.1 South Yangtze River Road, Taizhou City, , Jiangsu Province, China, 225321, Taizhou , Jiangsu, China
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 June 2024 - 21 June 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Yangtze River Pharmaceutical (Group) Co., Ltd. (5)

  • Esomeprazole Sodium for Injection
  • Pantoprazole Sodium for Injection
  • Amlodipine Besylate Tablets

    Product Amlodipine Besylate Tablets

    Yangtze river pharmaceutical group offer a wide range of circulatory system agents which includes amlodipine besylate tablets. Packaging: 5mg. Indications: it is used for infections caused by some sensitive bacteria strains: upper respiratory infections, lower respiratory infections, otorhino-laryngalogic ...
  • Anastrozole Tablets

    Product Anastrozole Tablets

    Yangtze river pharmaceutical group offer a wide range of anti-aliergic agents which includes anastrozole tablets. Packaging: 1mg. Indications: it is used to cure breast cancer at advanced age for women during post-menopause. Contact us for more information.

Yangtze River Pharmaceutical (Group) Co., Ltd. Resources (2)